There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on GE Healthcare Technologies Inc (GEHC – Research Report) and CervoMed (CRVO – Research Report) with bullish sentiments.
GE Healthcare Technologies Inc (GEHC)
In a report released today, Sezgi Oezener from HSBC initiated coverage with a Buy rating on GE Healthcare Technologies Inc and a price target of $100.00. The company’s shares closed last Wednesday at $83.17.
According to TipRanks.com, Oezener is ranked #6030 out of 8720 analysts.
GE Healthcare Technologies Inc has an analyst consensus of Moderate Buy, with a price target consensus of $88.70, which is a 7.4% upside from current levels. In a report issued on February 6, Wells Fargo also maintained a Buy rating on the stock with a $85.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
CervoMed (CRVO)
Canaccord Genuity analyst Sumant Kulkarni initiated coverage with a Buy rating on CervoMed yesterday and set a price target of $50.00. The company’s shares closed last Wednesday at $14.80, equals to its 52-week high of $14.80.
According to TipRanks.com, Kulkarni is a 4-star analyst with an average return of
Currently, the analyst consensus on CervoMed is a Moderate Buy with an average price target of $50.00.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on GEHC:
- Rivian downgraded, Loweâs upgraded: Wall Street’s top analyst calls
- GE HealthCare upgraded to Neutral from Sell at UBS
- GE HealthCare, Medquest enter three-year collaboration
- GE HealthCare price target raised to $93 from $86 at Evercore ISI
- GE HealthCare price target raised to $94 from $84 at Piper Sandler
